Part 2 completes the deep dive into what clinicians are not taught about SRIs. Dr. Nassir Ghaemi covers serotonin withdrawal syndrome, the evidence on long-term efficacy versus harm, and practical clinical recommendations for tapering and discontinuation. Building on Part 1, this episode challenges the assumption that indefinite SSRI maintenance is evidence-based, offering a data-driven framework for reassessing ongoing prescriptions. Subscribe at https://psychiatryletter.com